INDUSTRY PRESS

Latest news and updates that effect our business

Entrepreneur

"Why Are So Many Celebrities Investing In the CBD And Hemp Industry?" - Over the past few years, many high-profile celebrities have invested their considerable wealth into the CBD industry. It is becoming increasingly common to see stars across the world become...

read more

Newsweek

"Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac" - Two studies that have enrolled more than 300 patients in 10 countries were given "breakthrough therapy" status in 2018 and 2019 by the U.S. Food and Drug Administration (FDA), which...

read more

PR Newswire

"Psychedelic Decriminalization Creating Market Opportunities" - California is the latest state inching closer to decriminalizing shrooms, with a third city now pushing for legalization thanks to ongoing research into the benefits of psychedelics in the treatment and...

read more

Forbes

"Legal Cannabis Market Projected To Rack Up $43 Billion By 2025" - By 2025, 42% of the total annual U.S. cannabis demand is projected to be met by legal purchases in regulated marketplaces. This is a 24% jump from 2020.

read more

Rolling Stones

“Jews, Christians, and Muslims Are Reclaiming Ancient Psychedelic Practices, And That Could Help With Legalization” - Some advocates are focusing on the spiritual side of psychedelics as a way to decriminalize through religious exemption.

read more

LA Times

“Denver dabbles with magic mushrooms, but using them to treat mental health disorders remains underground” - Denver Police Division Chief says “There has been no effect that has been apparent to law enforcement,” since the decriminalization of hallucinogenic mushrooms...

read more

CNBC

“A psychedelic drug boom in mental health treatment comes closer to reality” - Companies like Compass Pathways, which uses psilocybin for depression, and Atai Life Sciences, backed by Peter Thiel, are researching a variety of ways to treat mental health with...

read more

NYT

“The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same.”- The first Phase 3 clinical trial conducted with psychedelic-assisted therapy, found that MDMA paired with counseling brought marked relief to patients with severe post-traumatic stress...

read more

BBC News

“Psilocybin: Magic mushroom compound 'promising' for depression” - A small, early-stage study has suggested that psilocybin is as good at reducing symptoms of depression as conventional treatment.

read more

Sign up to get the latest news about our company